Effect of oral granisetron in uremic pruritus

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 4, 2007, Pages 231-234

  Layegh, Pouran ^a   Mojahedi, Mohammad Javad ^a   Malekshah, Parisa Emamgholi Tabar ^a   Pezeshkpour, Fakhrozaman ^a   Vahedian, Mohamad ^b   Nazemian, Fatemeh ^c   Pour, Farzaneh Sharifi ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Continuous Ambulatory Peritoneal Dialysis; Granisetron; Hemodialysis; Uremic pruritus

Indexed keywords

ANTIHISTAMINIC AGENT; GRANISETRON; HISTAMINE; HYDROXYZINE; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRURITUS; QUESTIONNAIRE; TREATMENT RESPONSE; UREMIA; UREMIC PRURITUS;

EID: 34547652408     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.32887     Document Type: Article

References (27)

1. Parfery PS, Vasasour HM, Henry S, Bullock M, Gault MH. Clinical features and severity of non-specific symptoms in dialysis patients. Nephron 1988;50:121-8.
2. Balaskas EV, Oreopoulos DG. Uremic pruritus (part I). Dial Transpl 1992;21:192-205,244.
3. Dimcovic N, Djukanovic L, Radmilovic A, Bojic P, Juloski T. Uremic pruritus and skin mast cell. Nephron 1992;61:5-9.
4. Francos GC, Kauh YC, Gitllen SD, Schulman ES, Besarab A, Goyal S, et al. Elevated plasma histamine in chronic uremia: Effects of Ketotifen of prutitus. Int J Dermatol 1991;30:884-9.
5. Schwörer H, Ramadori G. Treatment of pruritus: A new indication for serotonin type 3 receptor antagonists. Clin Investig 1993:71:659-62.
6. Andrews PA, Quan V, Ogg CS. Ondansetron for symptomatic relief in terminal uremia. Nephrol Dial Transplant 1995;10:140.
7. Kerr PG, Argiles A, Mion C. Whole blood serotonin levels are markedly elevated in patients on dialytic therapy. Am J Nephrol 1992;12:14-8.
8. Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystan H. Ondansetron therapy for uremic patients in hemodialysis. Am J Kidney Dis 2000;35:827-31.
9. Murphy M, Reaich D, Pai P, Finns P, Carmichael AJ. A randomized, placebo -controlled, double -blind trial of ondansetron in uremic pruritus. Br J Dermatol 2003;148:314-7.
10. Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients. Nephron 1998;78:395-402.
11. Albares MP, Betlock I, Guijarro I, Vegara G, Pascual JC, Botella R. Severe pruritus in a haemodialysed patient: Dramatic improvement with granisetron. Br J Dermatol 2003;148:376-7.
12. Blower P. A pharmacologic profile of oral granisetron (Kytril tablets). Semin Oncol 1995;22:3-5.
13. Dilly S. Granisetron (Kytril) clinical safety and tolerance. Semin Oncol 1994;21:10-4.
14. Duo LJ. Electrical needle therapy of uremic pruritus. Nephron 1987;47:179-83.
15. Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kohlmann U. Uremic pruritus in patients on hemodialysis or continous ambulatory peritoneal dialysis (CAPD): The role of plasma histamine and skin mast cells. Clin Nephrol 1990;34:136-41.
16. Balaskas EV, Chu M, Uldall RP, Gupta A, Oreopoulos DG. Pruritus in continous ambulatory peritoneal dialysis and hemodialysis patients. Perit Dial Int 1993;13:527-532.
17. Akhyani M, Ganji MR, Samadi N, Khamesan B, Daneshpazooh M. Pruritus in hemodialysis patients. BMC Dermatol 2005;24:5-7.
18. Nielson T, Anderson KE, Kristiansen J. Pruritus and xerosis in patients with chronic renal failure. Dan Med Bull 1980;27:269-71.
19. Bencini PL, Montagnino G, Citterio A, Graziani G, Crosti C, Ponticelli C. Cutaneous abnormalities in uremic patients. Nephron 1985;40:316-21.
20. Stahle-Backdahl M, Hagermark O, Lings LE. Pruritus in patients on maintenance hemodialysis. Acta Med Scand 1988;224:55-60.
21. Gilchrest BA, Stern RS, Steinman T, Brown RS, Arndt K, Anderson WW. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 1982;118:154-6.
22. Matsumoto M, Ichimaru K, Hone A. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol 1985;23:285-8.
23. Young AW, Sweeney EW, David DS, Cheigh J, Hochgelerenl EL, Sakai S, et al. Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med 1973;73:2670-4.
24. Stockenhuber F, Sunder-Plassmann G, Blacke P. Increased plasma histamine levels in chronic renal failure. N Engl Med 1987;317:386.
25. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus - new perspectives and insights from recent trials. Nephrol Dial Tranplant 2002;17:1558-63
26. Dixon CM, Colthup PV, Serabjit-Singh CJ, Kerr BM, Boehlert CC, Park GR, et al. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. Drug Metab Dispos 1995;23:1225-30.
27. Aapro M. Granisetron: An update on its clinical use in the management of nausea and vomiting. Oncologist 2004;6:673-86.